Showing results (111-120 of 170) with videos related to

Sort By:
Pageof 17
Aging and Disease|August 26, 2017
P2X7 Receptor and APOE Polymorphisms and Survival from Heart Failure: A Prospective Study in Frail Patients in a Geriatric UnitGiuseppe Pasqualetti, Marta Seghieri, Eleonora Santini, et al.
Diabetes|February 2, 2018
PDGF-BB Carried by Endothelial Cell-Derived Extracellular Vesicles Reduces Vascular Smooth Muscle Cell Apoptosis in DiabetesGabriele Togliatto, Patrizia Dentelli, Arturo Rosso, et al.
Cardiovascular Diabetology|January 13, 2024
Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter StudyMartina Vitale, Emanuela Orsi, Anna Solini, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 10, 2025
Effect of bempedoic acid on incretin axis and systemic and liver inflammation: a pilot, monocentric studyChiara Rovera, Alice Del Zoppo, Giovanni Petralli, et al.
Panminerva Medica|May 9, 2024
Neglected cardiometabolic risk factors and subclinical target organ damage in post-menopausal women with normal glucose toleranceGiovanni Petralli, Edoardo Biancalana, Mariarosaria Distaso, et al.
American Journal of Physiology. Renal Physiology|February 1, 2007
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4Anna Solini, Eleonora Santini, Daniele Chimenti, et al.
Diabetes, Obesity & Metabolism|July 2, 2025
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney diseaseGian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.
Diabetes, Obesity & Metabolism|September 24, 2025
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world dataGian Paolo Fadini, Enrico Longato, Sara Poletto, et al.
Scientific Reports|January 22, 2020
miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic PotentialClaudia Cavallari, Federico Figliolini, Marta Tapparo, et al.
Journal of Diabetes and Its Complications|April 19, 2017
Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up studySaula Vigili de Kreutzenberg, Anna Solini, Edoardo Vitolo, et al.
Pageof 17